Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Condition(s):Benign Prostatic HyperplasiaLast Updated:March 15, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Benign Prostatic HyperplasiaLast Updated:March 15, 2024Recruiting
Condition(s):StrokeLast Updated:March 15, 2024Not yet recruiting
Condition(s):Peripheral Arterial DiseaseLast Updated:March 13, 2024Not yet recruiting
Condition(s):Gastric Antral Vascular Ectasia; CirrhosisLast Updated:March 12, 2024Not yet recruiting
Condition(s):Diffuse Midline Glioma, H3 K27M-Mutant; Recurrent High Grade GliomaLast Updated:March 12, 2024Recruiting
Condition(s):Hematopoietic and Lymphatic System Neoplasm; Malignant Solid NeoplasmLast Updated:March 12, 2024Recruiting
Condition(s):Idiopathic ScoliosisLast Updated:March 7, 2024Not yet recruiting
Condition(s):Fibrillary GlomerulonephritisLast Updated:March 6, 2024Not yet recruiting
Condition(s):Hypertrophic Cardiomyopathy; Athlete HeartLast Updated:March 4, 2024Not yet recruiting
Condition(s):Breast CarcinomaLast Updated:February 29, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.